BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 18445624)

  • 1. The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis.
    Liakouli V; Manetti M; Pacini A; Tolusso B; Fatini C; Toscano A; Cipriani P; Guiducci S; Bazzichi L; Codullo V; Ruocco L; Dell'orso L; Carubbi F; Marrelli A; Abbate R; Bombardieri S; Ferraccioli G; Montecucco C; Valentini G; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R
    Ann Rheum Dis; 2009 Apr; 68(4):584-90. PubMed ID: 18445624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis.
    Manetti M; Liakouli V; Fatini C; Cipriani P; Bonino C; Vettori S; Guiducci S; Montecucco C; Abbate R; Valentini G; Matucci-Cerinic M; Giacomelli R; Ibba-Manneschi L
    Ann Rheum Dis; 2009 Mar; 68(3):408-11. PubMed ID: 18930992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer.
    Jain M; Kumar S; Lal P; Tiwari A; Ghoshal UC; Mittal B
    Cancer Detect Prev; 2007; 31(3):225-32. PubMed ID: 17561354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients.
    Beretta L; Cappiello F; Moore JH; Barili M; Greene CS; Scorza R
    Arthritis Rheum; 2008 Jul; 59(7):974-83. PubMed ID: 18576303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The FAS -670A>G polymorphism influences susceptibility to systemic sclerosis phenotypes.
    Broen J; Gourh P; Rueda B; Coenen M; Mayes M; Martin J; Arnett FC; Radstake TR;
    Arthritis Rheum; 2009 Dec; 60(12):3815-20. PubMed ID: 19950259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus.
    Kanemitsu S; Ihara K; Saifddin A; Otsuka T; Takeuchi T; Nagayama J; Kuwano M; Hara T
    J Rheumatol; 2002 Jun; 29(6):1183-8. PubMed ID: 12064832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population.
    Ito I; Kawaguchi Y; Kawasaki A; Hasegawa M; Ohashi J; Hikami K; Kawamoto M; Fujimoto M; Takehara K; Sato S; Hara M; Tsuchiya N
    Arthritis Rheum; 2009 Jun; 60(6):1845-50. PubMed ID: 19479858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls.
    Young-Min SA; Beeton C; Laughton R; Plumpton T; Bartram S; Murphy G; Black C; Cawston TE
    Ann Rheum Dis; 2001 Sep; 60(9):846-51. PubMed ID: 11502611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allograft inflammatory factor-1 and tumor necrosis factor single nucleotide polymorphisms in systemic sclerosis.
    Otieno FG; Lopez AM; Jimenez SA; Gentiletti J; Artlett CM
    Tissue Antigens; 2007 Jun; 69(6):583-91. PubMed ID: 17498268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas promoter region gene polymorphism is associated with an increased risk for myocardial infarction.
    Hanasaki H; Takemura Y; Fukuo K; Ohishi M; Onishi M; Yasuda O; Katsuya T; Awata N; Kato N; Ogihara T; Rakugi H
    Hypertens Res; 2009 Apr; 32(4):261-4. PubMed ID: 19262492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of a functional CD19 polymorphism with susceptibility to systemic sclerosis.
    Tsuchiya N; Kuroki K; Fujimoto M; Murakami Y; Tedder TF; Tokunaga K; Takehara K; Sato S
    Arthritis Rheum; 2004 Dec; 50(12):4002-7. PubMed ID: 15593213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus.
    Lee YH; Kim YR; Ji JD; Sohn J; Song GG
    J Rheumatol; 2001 Sep; 28(9):2008-11. PubMed ID: 11550967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic sclerosis-rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity.
    Szücs G; Szekanecz Z; Zilahi E; Kapitány A; Baráth S; Szamosi S; Végvári A; Szabó Z; Szántó S; Czirják L; György Kiss C
    Rheumatology (Oxford); 2007 Jun; 46(6):989-93. PubMed ID: 17384178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proximal interleukin-10 gene polymorphisms in Italian patients with systemic sclerosis.
    Beretta L; Cappiello F; Barili M; Scorza R
    Tissue Antigens; 2007 Apr; 69(4):305-12. PubMed ID: 17389013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of IL-10 receptor 2 (IL10RB) SNP with systemic sclerosis.
    Hikami K; Ehara Y; Hasegawa M; Fujimoto M; Matsushita M; Oka T; Takehara K; Sato S; Tokunaga K; Tsuchiya N
    Biochem Biophys Res Commun; 2008 Aug; 373(3):403-7. PubMed ID: 18588853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemorheologic profile in systemic sclerosis: role of NOS3 -786T > C and 894G >T polymorphisms in modulating both the hemorheologic parameters and the susceptibility to the disease.
    Fatini C; Mannini L; Sticchi E; Rogai V; Guiducci S; Conforti ML; Cinelli M; Pignone AM; Bolli P; Abbate R; Cerinic MM
    Arthritis Rheum; 2006 Jul; 54(7):2263-70. PubMed ID: 16802365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas gene polymorphisms in systemic lupus erythematosus and serum levels of some apoptosis-related molecules.
    Arasteh JM; Sarvestani EK; Aflaki E; Amirghofran Z
    Immunol Invest; 2010; 39(1):27-38. PubMed ID: 20064083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. -238 and +489 TNF-alpha along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with Systemic Sclerosis.
    Tolusso B; Fabris M; Caporali R; Cuomo G; Isola M; Soldano F; Montecucco C; Valentini G; Ferraccioli G
    Immunol Lett; 2005 Jan; 96(1):103-8. PubMed ID: 15585313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease.
    Akman A; Sallakci N; Coskun M; Bacanli A; Yavuzer U; Alpsoy E; Yegin O
    Br J Dermatol; 2006 Aug; 155(2):350-6. PubMed ID: 16882174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.